SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-008656
Filing Date
2012-02-14
Accepted
2012-02-14 15:22:33
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v302219_10-q.htm 10-Q 524178
2 EXHIBIT 31.1 v302219_ex31-1.htm EX-31.1 9241
3 EXHIBIT 32.1 v302219_ex32-1.htm EX-32.1 6505
  Complete submission text file 0001144204-12-008656.txt   2187186

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctix-20111231.xml EX-101.INS 215388
5 XBRL TAXONOMY EXTENSION SCHEMA ctix-20111231.xsd EX-101.SCH 20468
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20111231_cal.xml EX-101.CAL 30742
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20111231_def.xml EX-101.DEF 113491
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20111231_lab.xml EX-101.LAB 150636
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20111231_pre.xml EX-101.PRE 132933
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 12608627
SIC: 2834 Pharmaceutical Preparations